Skip to main content
. 2014 Nov;58(11):6870–6878. doi: 10.1128/AAC.03775-14

FIG 2.

FIG 2

NMP efficacy with linezolid determined from gradient MIC testing (with the parental AcrB-overexpressing strain 3-AG100 and with site-directed-mutagenesis-generated AcrB mutants). Efficacy is reported as the ratio of the MICs in the absence and presence of NMP (values are means from at least four independent assays). Error bars indicate standard deviations (SD).